NCT03454945 Efficacy of Doxycycline in the Treatment of Early Stages of Mycosis Fungoides Status UNKNOWN Phase PHASE3
NCT03451825 Phase I/II Study of Avelumab in Pediatric Cancer Participants Status TERMINATED Phase PHASE1
NCT03436342 Chemokine Receptor CXCR4-targeting Molecular Imaging for Metabolic Characterization of Multiple Myeloma and Lymphoma Status UNKNOWN Phase EARLY_PHASE1
NCT03435250 Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss Status TERMINATED Phase PHASE1
NCT03422874 Dose Escalation Study of Nelfinavir Plus MLN9708 in Patients With Advanced Solid Tumors or Lymphoma Status WITHDRAWN Phase PHASE1
NCT03408561 Social Media Listening in Improving Clinical Trial Recruitment in Patients With Cancer Status WITHDRAWN Phase NA
NCT03407430 Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain Status TERMINATED Phase PHASE2
NCT03383055 CMV-MVA Triplex Vac.Enhance Adap. NK Cell Recon. After Auto HSCT in pt Lymphoid Malig Status COMPLETED Phase PHASE1
NCT03374007 Phase I Clinical Trial in Chinese Patients of Advanced and (or) Recurrent Solid Tumor/Lymphoma Status UNKNOWN Phase PHASE1
NCT03373526 Effects of Aerobic Training and Inspiratory Muscle Training in Patients During Hematopoietic Stem Cell Transplantation Status UNKNOWN Phase NA
NCT03361358 Pre-Screening Study to Identify MTAP Loss in Advanced Solid Tumors or Lymphoma Status COMPLETED Phase N/A
NCT03352765 A Phase I Study of Bendamustine and Melphalan Conditioning and Autologous Stem Cell Transplantation for Treatment of Multiple Myeloma and Relapsed/Refractory B-cell Lymphoma in Elderly Patients Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03344809 Enhancing Diagnosis in Chronic B-cell Lymphoproliferative Disorders Using Next-Generation Sequencing Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03336138 Application of Telemedicine to the Management of Aggressive Lymphomas Status COMPLETED Phase NA
NCT03330691 A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03322384 UCDCC#271: Phase I/II Trial of Epacadostat, Intralesional SD101, Radiotherapy in Patients With Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT03314974 Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders Status RECRUITING Phase PHASE2